March 11 (Reuters) - Sensorion SA ALSEN.PA :
* STRENGTHENS ITS FINANCIAL STRUCTURE BY ISSUING A EUR 4.7 MILLION NOMINAL
BOND
ISSUE SUBSCRIBED BY NEW EUROPEAN INVESTORS AND MANAGEMENT
* BPIFRANCE HAS SELECTED SENSORION FOR ITS PROGRAM "HUB HEALTH TECH"
* BOND ISSUE CONSISTS OF ONE (I) CONVERTIBLE BOND ISSUE1 FOR A NOMINAL
AMOUNT OF
€3,4 MILLION SUBSCRIBED BY SEVERAL NEW EUROPEAN INVESTORS
* BOND ISSUE ALSO FOR A NOMINAL AMOUNT OF €1.3 MILLION SUBSCRIBED BY THESE
SAME
EUROPEAN INVESTORS FOR AN AMOUNT OF €1 MILLION
* AND THE BALANCE BY THE COMPANY'S MANAGEMENT, MR. PATRICK LANGLOIS,
CHAIRMAN OF
THE BOARD OF DIRECTORS AND MS. NAWAL OUZREN, CEO
* PROCEEDS OF BOND ISSUE ARE INTENDED TO FINANCE EXPENSES, OVERHEAD COSTS,
DEVELOPMENT OF CO PRODUCTS UNTIL NEXT 2019 MILESTONE
* CONVERTIBLE BONDS AND BONDS WERE SUBSCRIBED AT 93% OF THEIR NOMINAL VALUE,
WILL
BE NON-INTEREST BEARING AND WILL MATURE ON MARCH 7, 2021.
Source text for Eikon: ID:nBw4Nnbf4a
Further company coverage: ALSEN.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))